New vaccine approval for cervical cancer May 23, 4:03
A new vaccine is expected to receive national approval to prevent infection with the virus that causes cervical cancer. Whether to be covered by the "regular vaccination" at public expense will be discussed separately.
Approval is expected for the Sylgard 9 that the pharmaceutical company “MSD” has applied for a vaccine that prevents infection with viruses that cause cervical cancer.
The direction of approval was announced on the 22nd at the MHLW council.
There are various kinds of cervical cancer viruses, but this vaccine is effective in preventing infection with more kinds of viruses than the two kinds of vaccines already sold in Japan. It has been.
Regarding the vaccines that have already been sold, they were covered by the “regular vaccination” that was publicly inoculated in 2013, but immediately after that many people complained of physical pain, etc. It will be seven years soon, with the exception of the temporary suspension of.
The new vaccine has been filed by a pharmaceutical company in 2015 and will be approved 5 years later.
The Ministry of Health, Labor and Welfare said that the examination took time because it carried out a more careful confirmation based on the history so far.
It is expected that it will be officially approved after about a month of proceedings, but it will be discussed separately as to whether it will be covered by the "regular vaccination" funded by public funds.